Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emily Helen Andersen
Institution:
Incyte (United States)
Observed institution:
Incyte (United States)
OpenAlex ID:
A5159355503
Safety and Feasibility of Reduced-Frequency Dosing of Axatilimab in Patients Treated in the AGAVE-201 Study
2026
·
Nosha Farhadfar
, Maria Sola Soto
, et al.
·
Blood Advances
PDF
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
